We show that chronic metformin pre-conditioning rescued AMPK activation in CKD mice, an effect that was associated with a reduction of CKD-induced NF-κB pathway and a subsequent decrease in the level of the macrophage/microglia M1 markers CD32, CD16, CD86, iNOS, and IL-1β. This evidence concerns the gene NFKB1 and chronic kidney disease.